Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S18A (MRPS18A) is a nuclear-encoded protein that is a structural constituent of the small 28S subunit of the mitochondrial ribosome in humans. It is involved in mitochondrial protein synthesis, critical for the translation of proteins encoded by mitochondrial DNA. This protein is a member of the ribosomal protein S18P family and shows sequence similarity to bacterial S18 proteins, though substantial sequence divergence is seen across species. MRPS18A is not a known pharmacological or therapeutic target, and there are no drugs with a described mechanism of action involving it. Genetic variants have been associated with disorders such as Fallopian tube adenocarcinoma and Leigh disease, but its role is not as a primary disease driver or drug target[1][3][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S18A (MRPS18A).